{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:33:03Z","timestamp":1791347583660,"version":"4.3.1"},"reference-count":26,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"unspecified","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2020-01183"],"award-info":[{"award-number":["2020-01183"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ALF","award":["RV-929554"],"award-info":[{"award-number":["RV-929554"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,5,19]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Compulsive sexual behaviour disorder is a new disorder in the International Classification of Diseases (ICD-11), and is associated with negative consequences in different areas of life. Evidence for pharmacological treatment of compulsive sexual behaviour disorder is weak and treatment options are limited. This proposed study will be the largest and the first randomised controlled trial comparing the efficacy and tolerability of two active drugs in compulsive sexual behaviour disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Eighty adult participants with compulsive sexual behaviour disorder according to ICD-11 will be randomised to receive either naltrexone 25\u201350\u2009mg or fluoxetine 20\u201340\u2009mg for 8\u2009weeks, followed by 6\u2009weeks without treatment. The study will be conducted in a subspecialised outpatient sexual medicine unit at Karolinska University Hospital, Stockholm, Sweden. The study is financed by grants and entirely independent of the manufacturers.<\/jats:p>\n                    <jats:p>Exclusion criteria include severe psychiatric or psychical illness, changes to concurrent medication and non-compatible factors contraindicating the use of either drug. The primary outcome measure is the Hypersexual Disorder: Current Assessment Scale (HD: CAS), and tolerability will be assessed by the Udvalg for Kliniske Undersogelser side effect rating scale (UKU), drug accountability, adherence to treatment and drop-out rate. Participants will complete questionnaires at regular intervals, with the main endpoint for efficacy after 8 weeks (end of treatment) and after 14 weeks (follow-up). Blood chemistry will be repeatedly collected as a safety precaution and for research purposes. The results will be analysed using an appropriate analysis of variance model or a mixed model, depending on the distribution of HD: CAS and the extent of missing data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The Swedish Ethical Review Authority and the Swedish Medical Products Agency have approved the study on 27 May 2020 and 4 June 2020, respectively (ref. no. 2020-02069 and ref. no. 5.1-2020-48282). Findings will be published in peer-reviewed journals and presented at relevant conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>2019-004255-36<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-051756","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T11:36:05Z","timestamp":1654256165000},"page":"e051756","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["A randomised controlled trial of fluoxetine versus naltrexone in compulsive sexual behaviour disorder: presentation of the study protocol"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0140-4109","authenticated-orcid":false,"given":"Josephine","family":"Savard","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences\/Psychiatry, Umea University, Umea, Sweden"},{"name":"ANOVA clinic, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"G\u00f6rts \u00d6berg","sequence":"additional","affiliation":[{"name":"ANOVA clinic, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Dhejne","sequence":"additional","affiliation":[{"name":"ANOVA clinic, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Jokinen","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences\/Psychiatry, Umea University, Umea, Sweden"},{"name":"Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"2025121222310511000_12.6.e051756.1","unstructured":"World Health Organization . The 11th revision of the International classification of diseases (ICD-11). Available: https:\/\/icd.who.int\/browse11\/l-m\/en#\/http%3a%2f%2fid.who.int%2ficd%2fentity%2f274880002 [Accessed 9 Feb 2020]."},{"key":"2025121222310511000_12.6.e051756.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2008.06.005"},{"key":"2025121222310511000_12.6.e051756.3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1556\/2006.5.2016.046","article-title":"Paroxetine treatment of problematic pornography use: a case series","volume":"5","author":"Gola","year":"2016","journal-title":"J Behav Addict"},{"key":"2025121222310511000_12.6.e051756.4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/14789949.2017.1337801","article-title":"Evaluation of the use of pharmacological treatment with prisoners experiencing high levels of hypersexual disorder","volume":"29","author":"Winder","year":"2018","journal-title":"J Forens Psychiatry Psychol"},{"key":"2025121222310511000_12.6.e051756.5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00004850-200207000-00008","article-title":"Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies","volume":"17","author":"Raymond","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"2025121222310511000_12.6.e051756.6","doi-asserted-by":"crossref","first-page":"982","DOI":"10.4088\/JCP.v65n0715","article-title":"Naltrexone in the treatment of adolescent sexual offenders","volume":"65","author":"Ryback","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"2025121222310511000_12.6.e051756.7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/104012371002200108","article-title":"Augmentation with naltrexone to treat compulsive sexual behavior: a case series","volume":"22","author":"Raymond","year":"2010","journal-title":"Ann Clin Psychiatry"},{"key":"2025121222310511000_12.6.e051756.8","doi-asserted-by":"publisher","DOI":"10.4065\/83.2.226"},{"key":"2025121222310511000_12.6.e051756.9","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1218"},{"key":"2025121222310511000_12.6.e051756.10","doi-asserted-by":"publisher","DOI":"10.1080\/009262399278760"},{"key":"2025121222310511000_12.6.e051756.11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/0092623X.2014.935539","article-title":"Patient characteristics by type of hypersexuality referral: a quantitative chart review of 115 consecutive male cases","volume":"41","author":"Sutton","year":"2015","journal-title":"J Sex Marital Ther"},{"key":"2025121222310511000_12.6.e051756.12","doi-asserted-by":"publisher","DOI":"10.1177\/107906320301500407"},{"key":"2025121222310511000_12.6.e051756.13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8020157","article-title":"Same Same but Different: A Clinical Characterization of Men with Hypersexual Disorder in the Sex@Brain Study","volume":"8","author":"Engel","year":"2019","journal-title":"J Clin Med"},{"key":"2025121222310511000_12.6.e051756.14","doi-asserted-by":"publisher","DOI":"10.3109\/15622971003671628"},{"key":"2025121222310511000_12.6.e051756.15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/15622975.2020.1744723","article-title":"The world Federation of societies of biological psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders","volume":"21","author":"Thibaut","year":"2020","journal-title":"World J Biol Psychiatry"},{"key":"2025121222310511000_12.6.e051756.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2013.05.005"},{"key":"2025121222310511000_12.6.e051756.17","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jsxm.2020.04.318","article-title":"Naltrexone in compulsive sexual behavior disorder: a feasibility study of twenty men","volume":"17","author":"Savard","year":"2020","journal-title":"J Sex Med"},{"key":"2025121222310511000_12.6.e051756.18","article-title":"The Mini-International neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59 Suppl 20","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"2025121222310511000_12.6.e051756.19","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10111704"},{"key":"2025121222310511000_12.6.e051756.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-009-9574-7"},{"key":"2025121222310511000_12.6.e051756.21","unstructured":"American Psychiatric Association . Hypersexual Disorder: current assessment scale. American Psychatric Association\u2019s DSM-V workgroup on Sexual and Gender Identity Disorders, 2010. Available: http:\/\/www.dsm5.org\/ProposedRevisions\/Pages\/proposedrevision.aspx?rid=415 [Accessed Mar 2010]."},{"key":"2025121222310511000_12.6.e051756.22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/10720162.2011.555709","article-title":"Reliability, validity, and psychometric development of the Hypersexual behavior inventory in an outpatient sample of men","volume":"18","author":"Reid","year":"2011","journal-title":"Sex Addict Compulsivity"},{"key":"2025121222310511000_12.6.e051756.23","doi-asserted-by":"publisher","DOI":"10.1207\/s15327752jpa6503_16"},{"key":"2025121222310511000_12.6.e051756.24","first-page":"5","article-title":"Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. clinical validation of a self-rating version of the UKU side effect rating scale (UKU-SERS-Pat)","volume":"55 Suppl 44","author":"Lindstr\u00f6m","year":"2001","journal-title":"Nord J Psychiatry"},{"key":"2025121222310511000_12.6.e051756.25","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.jsxm.2020.07.018","article-title":"Internet-Administered Cognitive Behavioral Therapy for Hypersexual Disorder, With or Without Paraphilia(s) or Paraphilic Disorder(s) in Men: A Pilot Study","volume":"17","author":"Hallberg","year":"2020","journal-title":"J Sex Med"},{"key":"2025121222310511000_12.6.e051756.26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2020.101925","article-title":"Sexual addiction 25\u00a0years on: A systematic and methodological review of empirical literature and an agenda for future research","volume":"82","author":"Grubbs","year":"2020","journal-title":"Clin Psychol Rev"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-051756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:31:18Z","timestamp":1765607478000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-051756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,3]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/bmjopen-2021-051756"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-051756","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}